NCT01703585View on ClinicalTrials.gov

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 4, 2012

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Colorectal CancerBreast CancerGynecological CancerMetastaticEligible for Phase I or Phase II StudyMelanoma Cancer
Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

Ontario Institute for Cancer Research

OTHER

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER